Nagoya, Japan

Tetsuya Tsukamoto

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tetsuya Tsukamoto. Retrieved from https://idiyas.com/inventor/tetsuya-tsukamoto-uink5r1m

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,570 
Other
 patents

Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tetsuya Tsukamoto: Innovator in Anti-Inflammatory and Cancer-Preventive Agents

Introduction

Tetsuya Tsukamoto is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory and cancer-preventive agents. His innovative work has the potential to impact health and wellness positively.

Latest Patents

Tetsuya Tsukamoto holds a patent for an anti-inflammatory agent and cancer-preventive agent comprising canolol or a prodrug thereof. This patent also includes pharmaceutical, cosmetic, and food products that utilize this innovative compound. The specific patent involves 4-vinyl-2,6-dimethoxyphenol, which is a key component in his research.

Career Highlights

Throughout his career, Tetsuya has focused on the intersection of chemistry and health. His dedication to research and development has led to advancements in treatments that could benefit many individuals suffering from inflammatory conditions and cancer.

Collaborations

Tetsuya has worked alongside talented colleagues, including Hiroshi Maeda and Masae Tatematsu. Their collaborative efforts have contributed to the success of his research and the development of his patented inventions.

Conclusion

Tetsuya Tsukamoto is a distinguished inventor whose work in anti-inflammatory and cancer-preventive agents showcases his commitment to improving health outcomes. His innovative contributions continue to pave the way for future advancements in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…